180 related articles for article (PubMed ID: 7387148)
1. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
Vazquez GJ; Archer GL
Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Archer GL; Vazquez GJ; Johnston JL
J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
[TBL] [Abstract][Full Text] [Related]
3. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
5. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
Berry AJ; Johnston JL; Archer GL
Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
[TBL] [Abstract][Full Text] [Related]
6. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
Kobasa WD; Kaye KL; Shapiro T; Kaye D
Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
[TBL] [Abstract][Full Text] [Related]
8. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
Chambers HF; Sande MA
Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
[TBL] [Abstract][Full Text] [Related]
9. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies.
Archer GL; Johnston JL; Vazquez GJ; Haywood HB
Rev Infect Dis; 1983; 5 Suppl 3():S538-42. PubMed ID: 6556710
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.
Lowy FD; Walsh JA; Mayers MM; Klein RS; Steigbigel NH
Antimicrob Agents Chemother; 1979 Sep; 16(3):314-21. PubMed ID: 259421
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.
Archer GL
Antimicrob Agents Chemother; 1978 Sep; 14(3):353-9. PubMed ID: 708013
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
18. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Miró JM; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres CA; Gatell JM; Jiménez de Anta MT; Marco F;
Antimicrob Agents Chemother; 2009 Oct; 53(10):4172-7. PubMed ID: 19620326
[TBL] [Abstract][Full Text] [Related]
19. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
Climo MW; Patron RL; Archer GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.
Baddour LM; Hill MM; Felty-Duckworth AM
Infection; 1989; 17(2):90-6. PubMed ID: 2714864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
